サポート>ブログ>Biointronがわずか2週間で成果を提供

Biointronがわずか2週間で成果を提供

Biointron 2025-01-13

Antibody_IgG1_surface

Biointron, established in 2012 and ISO 9001:2015 certified, is a leading Contract Research Organization (CRO) specializing in antibody discovery, optimization, and expression services for biotech and pharmaceutical companies worldwide.

Leveraging over a decade of experience, we have developed a high-throughput (HTP) recombinant antibody production platform that delivers purified antibodies from gene sequences in just two weeks.

This accelerated timeline is achieved through a streamlined workflow encompassing in-house gene synthesis, plasmid construction, transient expression in HEK293 or CHO cells, and stringent quality control measures. The process begins with codon optimization and gene synthesis, followed by subcloning into an expression vector. After plasmid amplification, transient transfection of mammalian cells is performed, leading to antibody expression and subsequent purification. Quality control includes SDS-PAGE analysis to ensure purity exceeds 95%, low endotoxin levels, and size-exclusion high-performance liquid chromatography (SEC-HPLC) detection.

Our commitment to rapid and reliable antibody production has attracted over 2,000 global biotech and pharmaceutical partners, including industry leaders such as AstraZeneca, AbbVie, Moderna, Sanofi, and Merck KGaA. These collaborations underscore Biointron's reputation for delivering high-quality antibodies with minimal batch-to-batch variation, meeting stringent industry standards.

In addition to recombinant antibody production, we offer a comprehensive suite of services, including bispecific antibody production, large-scale antibody production, protein expression in mammalian systems, single B-cell screening, CHO-K1 stable cell line generation, VHH antibody discovery, antibody humanization, and affinity maturation. This extensive service portfolio positions Biointron as a one-stop solution for antibody discovery and optimization needs.

Biointron's dedication to excellence, customer-centric approach, and passion for advancing biotechnology make it a trusted partner for researchers and developers seeking efficient and high-quality antibody solutions. Contact us at info@biointron.com or +1 (732) 790-8340.


Subscribe to our ブログ
Recommended Articles
Integrating Developability Screening Earlier in Antibody Discovery

For an antibody candidate, strong target binding is only part of the path toward……

Jul 17, 2026
VHH-Based Biosensors: Precision Tools for High-Sensitivity Detection

Explore VHH-based biosensors for high-sensitivity detection using nanobodies in ……

Jul 15, 2026
Antibodies After Hours: BIO 2026 Reception – Event Recap

Biointron’s Antibodies After Hours: BIO 2026 Reception was held at The Lion's Sh……

Jul 13, 2026
Stabilizing Protein Conformations and Facilitating Structural Resolution Using VHH Antibodies

Explore how VHH antibodies stabilize protein conformations for crystallography, ……

Jul 11, 2026

当サイトでは、お客様の利便性向上のためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。